MEDIVIC
Live / Registered — Registered (as of 05 Nov 2019)
What this means for you
Registered since 05 Nov 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use was filed 03 Mar 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 79249332
- Registration number
- 5899667
- Mark type
- Word mark
- Filed
- 03 Oct 2018
- Published for opposition
- 20 Aug 2019
- Registered
- 05 Nov 2019
- Next maintenance filing
- §71 affidavit of use, filed 03 Mar 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Sang N. Dang
Goods and services
- Class 005 — Pharmaceuticals: Mineral dietary supplements for humans; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases
Owner
Prosecution history
- 29 Jun 2026 — OFFICE ACTION ISSUED POU2
- 21 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 21 Mar 2026 — OFFICE ACTION ISSUED POU1
- 14 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Mar 2026 — TEAS SECTION 71 & 15 RECEIVED
- 21 Mar 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 04 Mar 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 04 Mar 2020 — FINAL DISPOSITION PROCESSED
- 05 Feb 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2019 — PUBLISHED FOR OPPOSITION
- 16 Aug 2019 — NOTIFICATION PROCESSED BY IB
- 31 Jul 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 31 Jul 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 31 Jul 2019 — NOTICE OF PUBLICATION